Oxford’s cheap, single-dose rabies vaccine passes Phase 1 human trials
A new single-shot rabies vaccine developed by researchers from the University of Oxford is showing promising results following a Phase 1 human clinical trial. Further clinical trials are now underway in the hopes the vaccine could help cut down the tho… Continue reading Oxford’s cheap, single-dose rabies vaccine passes Phase 1 human trials